Secondary 2026 summaries describe retatrutide producing liver-fat reductions of up to 86%, attributed mechanistically to the glucagon component, though the underlying MASLD paper is not surfaced in the sources reviewed here [1] [unverified]
She has a BA from Tulane University and an MFA in Writing from Sarah Lawrence College
The case against: more compounds means more injections, more variables, and more chances for something to interact badly
The US Food and Drug Administration only approved exenatide to treat type-2 diabetes in 2005
it is linked to regulation of cortisol and ACTH, potentially normalizing HPA axis function
Most strikingly, approximately 60% of tirzepatide patients had achieved normal blood sugar levels after two years, compared to 24% in the control group